Back to funds
View filing
MONTANOVA CAPITAL, LLC
hedge fundUpdated 27 days agoManaged by Suvretta Capital Management, Llc • Latest filing Q2 2026
Portfolio value
$5.5B
Q2 2026
Filings
14
Quarterly 13F history
Top-10 concentration
87.0%
Weight of largest holdings
Annualized return
18.3%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 14 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $2.4B |
| Q2 2023 | $1.9B |
| Q3 2023 | $1.9B |
| Q4 2023 | $2.2B |
| Q1 2024 | $2.7B |
| Q2 2024 | $2.7B |
| Q3 2024 | $3.1B |
| Q4 2024 | $2.9B |
| Q1 2025 | $2.7B |
| Q2 2025 | $3.3B |
| Q3 2025 | $3.9B |
| Q4 2025 | $4.9B |
| Q1 2026 | $3.9B |
| Q2 2026 | $5.5B |
Top holdings
96 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | S SPY STATE STR SPDR S&P 500 ETF T | $709.4M | 950.0K | 12.97% | — |
| 2 | M MANE VERADERMICS INC | $512.5M | 4.17M | 9.37% | — |
| 3 | A ARQT ARCUTIS BIOTHERAPEUTICS INC | $326.1M | 12.44M | 5.96% | — |
| 4 | L LEGN LEGEND BIOTECH CORP | $204.2M | 7.07M | 3.73% | — |
| 5 | P PVLA PALVELLA THERAPEUTICS INC NE | $173.5M | 1.14M | 3.17% | — |
| 6 | ? N/A ARRIVENT BIOPHARMA INC | $156.9M | 4.52M | 2.87% | — |
| 7 | B BNTC BENITEC BIOPHARMA INC | $154.5M | 11.55M | 2.83% | — |
| 8 | B BHVN BIOHAVEN LTD | $153.1M | 10.29M | 2.80% | — |
| 9 | A AMD ADVANCED MICRO DEVICES INC | $149.4M | 257.2K | 2.73% | — |
| 10 | R RCUS ARCUS BIOSCIENCES INC | $147.3M | 4.78M | 2.69% | — |
| 11 | T TSMWF TAIWAN SEMICONDUCTOR MANUFAC | $145.5M | 304.6K | 2.66% | — |
| 12 | N NVDA NVIDIA CORPORATION | $144.2M | 720.6K | 2.64% | — |
| 13 | ? N/A EYEPOINT INC | $118.6M | 8.30M | 2.17% | — |
| 14 | S SYY SYSCO CORP | $118M | 1.41M | 2.16% | — |
| 15 | G GE GE AEROSPACE | $116M | 310.3K | 2.12% | — |
| 16 | I IMTX IMMATICS N.V | $113.4M | 11.19M | 2.07% | — |
| 17 | M MGM MGM RESORTS INTERNATIONAL | $111.2M | 2.33M | 2.03% | — |
| 18 | M META META PLATFORMS INC | $99M | 175.8K | 1.81% | — |
| 19 | C CAPR CAPRICOR THERAPEUTICS INC | $98.6M | 4.09M | 1.80% | — |
| 20 | K KURA KURA ONCOLOGY INC | $94.1M | 8.58M | 1.72% | — |